Pharmacokinetic aspects of deprenyl effects

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Deprenyl is a selective, irreversible inhibitor of monoamine oxidase type-B (MAO-B). In prolonged treatment (0.05-0.25 mg/kg, sc daily) in spite of the irreversible blocking, selective inhibition pattern of MAO was maintained. 14C-Deprenyl is well absorbed after oral or subcutaneous administration and penetrates rapidly to the central nervous system. When it is given intravenously its highest brain concentration is reached within 30 sec but radioactivity rapidly disappears from the central nervous system. Deprenyl is metabolized to amphetamine and methylamphetamine in rats without producing a remarkable sign of psychostimulant activity. This could partly be due to the distribution properties of deprenyl e.g. low detectable level of radioactivity in the brain after 1-2 min and partly to the fact that from (-) -deprenyl (-) -amphetamines, which have less psychostimulant activity than the (+) -isomere, are formed.

Original languageEnglish
Pages (from-to)373-384
Number of pages12
JournalPolish Journal of Pharmacology and Pharmacy
Volume36
Issue number4
Publication statusPublished - 1984

Fingerprint

Selegiline
Pharmacokinetics
Monoamine Oxidase
Radioactivity
Central Nervous System
Amphetamines
Monoamine Oxidase Inhibitors
Methamphetamine
Brain
Amphetamine

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

Pharmacokinetic aspects of deprenyl effects. / Magyar, K.; Tóthfalusi, L.

In: Polish Journal of Pharmacology and Pharmacy, Vol. 36, No. 4, 1984, p. 373-384.

Research output: Contribution to journalArticle

@article{b8d78797246c461db266ad7e6ce495bb,
title = "Pharmacokinetic aspects of deprenyl effects",
abstract = "Deprenyl is a selective, irreversible inhibitor of monoamine oxidase type-B (MAO-B). In prolonged treatment (0.05-0.25 mg/kg, sc daily) in spite of the irreversible blocking, selective inhibition pattern of MAO was maintained. 14C-Deprenyl is well absorbed after oral or subcutaneous administration and penetrates rapidly to the central nervous system. When it is given intravenously its highest brain concentration is reached within 30 sec but radioactivity rapidly disappears from the central nervous system. Deprenyl is metabolized to amphetamine and methylamphetamine in rats without producing a remarkable sign of psychostimulant activity. This could partly be due to the distribution properties of deprenyl e.g. low detectable level of radioactivity in the brain after 1-2 min and partly to the fact that from (-) -deprenyl (-) -amphetamines, which have less psychostimulant activity than the (+) -isomere, are formed.",
author = "K. Magyar and L. T{\'o}thfalusi",
year = "1984",
language = "English",
volume = "36",
pages = "373--384",
journal = "Pharmacological Reports",
issn = "1734-1140",
publisher = "Polish Academy of Sciences Publishing House",
number = "4",

}

TY - JOUR

T1 - Pharmacokinetic aspects of deprenyl effects

AU - Magyar, K.

AU - Tóthfalusi, L.

PY - 1984

Y1 - 1984

N2 - Deprenyl is a selective, irreversible inhibitor of monoamine oxidase type-B (MAO-B). In prolonged treatment (0.05-0.25 mg/kg, sc daily) in spite of the irreversible blocking, selective inhibition pattern of MAO was maintained. 14C-Deprenyl is well absorbed after oral or subcutaneous administration and penetrates rapidly to the central nervous system. When it is given intravenously its highest brain concentration is reached within 30 sec but radioactivity rapidly disappears from the central nervous system. Deprenyl is metabolized to amphetamine and methylamphetamine in rats without producing a remarkable sign of psychostimulant activity. This could partly be due to the distribution properties of deprenyl e.g. low detectable level of radioactivity in the brain after 1-2 min and partly to the fact that from (-) -deprenyl (-) -amphetamines, which have less psychostimulant activity than the (+) -isomere, are formed.

AB - Deprenyl is a selective, irreversible inhibitor of monoamine oxidase type-B (MAO-B). In prolonged treatment (0.05-0.25 mg/kg, sc daily) in spite of the irreversible blocking, selective inhibition pattern of MAO was maintained. 14C-Deprenyl is well absorbed after oral or subcutaneous administration and penetrates rapidly to the central nervous system. When it is given intravenously its highest brain concentration is reached within 30 sec but radioactivity rapidly disappears from the central nervous system. Deprenyl is metabolized to amphetamine and methylamphetamine in rats without producing a remarkable sign of psychostimulant activity. This could partly be due to the distribution properties of deprenyl e.g. low detectable level of radioactivity in the brain after 1-2 min and partly to the fact that from (-) -deprenyl (-) -amphetamines, which have less psychostimulant activity than the (+) -isomere, are formed.

UR - http://www.scopus.com/inward/record.url?scp=0021631639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021631639&partnerID=8YFLogxK

M3 - Article

C2 - 6441926

AN - SCOPUS:0021631639

VL - 36

SP - 373

EP - 384

JO - Pharmacological Reports

JF - Pharmacological Reports

SN - 1734-1140

IS - 4

ER -